A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Honeywell (NYSE: HON) announced today that the same Spectra® fiber technology used in protective vests for law enforcement is now available to shield the belongings of everyday consumers from thieves who slash bags to steal items.
Consumers who want to keep their belongings safe can now buy a theft-resistant drawstring backpack called the Flak Sack, designed by Loctote Industrial Bag Company. As seen on ABC’s “Shark Tank,” the Flak Sack is the world’s first cut-resistant bag designed for travel and daily use. Now, it will be enhanced with Spectra—the same fiber technology used in bullet-resistant vests. Flak Sack utilizes Spectra in a unique fabric construction called FLAKnit™ created by Tuff-N-Lite®, a division of Supreme Corp., a leading textile and fiber technology company. Yet, despite this durability, Flak Sack is flexible, making it ideal for a range of situations such as travel, hiking and everyday use such as commuting to work.
To view the multimedia release go to:
https://www.multivu.com/players/English/8083951-honeywell-spectra-fiber-flak-sack-cut-resistant-bag/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
